These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20847434)

  • 1. Ocular biomarkers for early detection of Alzheimer's disease.
    Frost S; Martins RN; Kanagasingam Y
    J Alzheimers Dis; 2010; 22(1):1-16. PubMed ID: 20847434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma beta-amyloid as potential biomarker of Alzheimer disease: possibility of diagnostic tool for Alzheimer disease.
    Takeda S; Sato N; Rakugi H; Morishita R
    Mol Biosyst; 2010 Oct; 6(10):1760-6. PubMed ID: 20567751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. I read recently about an inexpensive new eye test that can diagnose Alzheimer's disease in its early stage. Since Alzheimer's runs in our family, we're very interested in learning more. Is the test generally available and how does it work?
    Duke Med Health News; 2007 Aug; 13(8):12. PubMed ID: 17703515
    [No Abstract]   [Full Text] [Related]  

  • 4. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Alzheimer's disease: the next 10 years.
    Hampel H; Prvulovic D; Teipel S; Jessen F; Luckhaus C; Frölich L; Riepe MW; Dodel R; Leyhe T; Bertram L; Hoffmann W; Faltraco F;
    Prog Neurobiol; 2011 Dec; 95(4):718-28. PubMed ID: 22137045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biomarkers for early diagnosis of Alzheimer's disease: current update and future directions].
    Malaplate-Armand C; Desbene C; Pillot T; Olivier JL
    Rev Neurol (Paris); 2009; 165(6-7):511-20. PubMed ID: 19041993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease: biological aspects, therapeutic perspectives and diagnostic tools.
    Di Carlo M; Giacomazza D; San Biagio PL
    J Phys Condens Matter; 2012 Jun; 24(24):244102. PubMed ID: 22595372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for Alzheimer's disease.
    Ward M
    Expert Rev Mol Diagn; 2007 Sep; 7(5):635-46. PubMed ID: 17892369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease in the human eye. Clinical tests that identify ocular and visual information processing deficit as biomarkers.
    Chang LY; Lowe J; Ardiles A; Lim J; Grey AC; Robertson K; Danesh-Meyer H; Palacios AG; Acosta ML
    Alzheimers Dement; 2014 Mar; 10(2):251-61. PubMed ID: 24011928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers in preclinical Alzheimer's disease.
    Chong MS; Lim WS; Sahadevan S
    Curr Opin Investig Drugs; 2006 Jul; 7(7):600-7. PubMed ID: 16869111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid imaging: from benchtop to bedside.
    Wu C; Pike VW; Wang Y
    Curr Top Dev Biol; 2005; 70():171-213. PubMed ID: 16338342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optometric management of patients with Alzheimer's disease.
    Baker DR; Mendez MF; Townsend JC; Ilsen PF; Bright DC
    J Am Optom Assoc; 1997 Aug; 68(8):483-94. PubMed ID: 9279048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF biomarkers for mild cognitive impairment and early Alzheimer's disease.
    Andreasen N; Blennow K
    Clin Neurol Neurosurg; 2005 Apr; 107(3):165-73. PubMed ID: 15823670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibre diffraction of hair can provide a screening test for Alzheimer's disease: a human and animal model study.
    James VJ; Richardson JC; Robertson TA; Papadimitriou JM; Dutton NS; Maley MA; Berstein LM; Lantseva OE; Martins RN
    Med Sci Monit; 2005 Feb; 11(2):CR53-7. PubMed ID: 15668631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-versus late-onset Alzheimer's disease: more than age alone.
    Koedam EL; Lauffer V; van der Vlies AE; van der Flier WM; Scheltens P; Pijnenburg YA
    J Alzheimers Dis; 2010; 19(4):1401-8. PubMed ID: 20061618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease.
    Schmand B; Huizenga HM; van Gool WA
    Psychol Med; 2010 Jan; 40(1):135-45. PubMed ID: 19863841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging and biomarkers for Alzheimer's disease.
    Allan CL; Sexton CE; Welchew D; Ebmeier KP
    Maturitas; 2010 Feb; 65(2):138-42. PubMed ID: 20060241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma biomarkers for mild cognitive impairment and Alzheimer's disease.
    Song F; Poljak A; Smythe GA; Sachdev P
    Brain Res Rev; 2009 Oct; 61(2):69-80. PubMed ID: 19464319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular biomarkers of Alzheimer's disease.
    Heaton GR; Davis BM; Turner LA; Cordeiro MF
    Cent Nerv Syst Agents Med Chem; 2015; 15(2):117-25. PubMed ID: 25788142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid tau, A beta, and phosphorylated tau protein for the diagnosis of Alzheimer's disease.
    Formichi P; Battisti C; Radi E; Federico A
    J Cell Physiol; 2006 Jul; 208(1):39-46. PubMed ID: 16447254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.